天发娱乐棋牌_天发娱乐APP-官网|下载

图片

图片

Skip to main navigation Skip to main content
The University of 天发娱乐棋牌_天发娱乐APP-官网|下载

MUSTANG

Title

Investigating the role of Miglustat in the management of a patient with Tangier’s Disease: a single case experiment.

Description

MUSTANG is an n-of-1 trial of ABAB design which aims to determine, in a single patient, the efficacy of Miglustat to improve cholesterol metabolism and resulting neuropathy caused by Tangier disease.

Objectives

Primary Objective

·?????? To determine the efficacy of Miglustat to improve arm fine motor control, finger dexterity and grip strength.

Secondary Objective

·?????? To determine the efficacy of Miglustat to improve Quality of Life, activities of daily living, aerobic capacity, endurance, ambulation and nerve conduction.

Mechanistic Objective

·?????? To investigate the potential mechanisms by which Miglustat does, or does not, have an effect.

Trial Design

This is an n-of-1 study of ABAB design, with alternating periods of intervention and control.

Trial Status

In progress, closed to recruitment.

Population

A single patient with Tangier disease, who is already known to the chief investigator, and keen to try the intervention.

This trial is funded by a National Institute for Health and Care Research grant (award reference no. NIHR132844)

Senior Trial Manager:

Frances Webley

Trial Coordinator:

Tom Oliver

Contact information:

Email: mustang@soton.ac.uk

SAE Reporting:

Email: ctu@soton.ac.uk

Esstential Trial Documents

MUSTANG Protocol v3 03-Mar-2022

MUSTANG PIS v3 03-Mar-2022

MUSTANG GP Letter v1 11-Dec-2020

MUSTANG Consent Form v3 03-Mar-2022

MUSTANG Dietary Diary v1 21-Jan 2021

MUSTANG Overall Neuropathy Limitations Scale v2 05-Mar-2021

MUSTANG RODS for GBS CIPD

MUSTANG EQ-5D-5L User Guide

MUSTANG EQ-5D-5L Paper Self-Complete v1.2

MUSTANG EQ-5D-5L Paper Interviewer Administration v1.4

MUSTANG Pregnant Partner PIS v0.3 12-Aug-2021

MUSTANG Pregnant Partner consent form v0.1 19-May-2021

ISF Documents

MUSTANG -Instructions for Adverse and Serious Adverse Event Reporting v1 09-Mar-2021

MUSTANG - SAE-SUSAR Report Form v1 09-Mar-2021

MUSTANG - Adverse Event Form v1 11-Mar-2021

MUSTANG - Master Patient List v1 26-Nov-2020

MUSTANG - Pre-Visit Checklists v1 16-Feb-2021

MUSTANG - Site Visit Log v1 04-Jan-2021

MUSTANG - Study Contacts and Information Page v1 27-Nov-2020

IMP Documents

MUSTANG - Pharmacy Manual v1 20-May-2021

MUSTANG - Drug Accountability Log v2 01-Apr-2021

MUSTANG - Summary of Product Characteristics (SmPC) 18-Nov 202

Laboratory Documents

MUSTANG - Laboratory Manual v3 20-Apr-2021

MUSTANG - Plasma Sample Storage Log v1 24-Feb-2021

MUSTANG - Urine Sample Storage Log v1 12-Mar-2021

MUSTANG - Sample Shipment Log - Dried Blood Sport Filtercard v1 25-Feb-2021

MUSTANG - Sample Shipment Log - EDTA 10ml v1 04-Mar-2021

MUSTANG - Sampling Worksheet - EDTA 10ml for Platt Lab

MUSTANG - Sampling Worksheet - Li-heparin (6ml), Random Urine (5ml) for GOH

MUSTANG - Willink Referral Form 1

Case Report Forms

MUSTANG - Trial Registration Form v1 09-Feb-2021

MUSTANG - End of Study CRF v2 31-Mar-2021

MUSTANG - Pregnancy Report Form v1 31-Mar-2021

MUSTANG - CRF 01 Eligibility, Registration and Baseline v2 31-Mar-2021

MUSTANG - CRF 02 Patient Contact Details v2 31-Mar-2021

MUSTANG - CRF 03 Concomitant Medications v2 31-Mar-2021

MUSTANG - CRF 04 Medical History v2 31-Mar-2021

MUSTANG - CRF 05 Month 2, v2 31-Mar-2021

MUSTANG - CRF 06 Month 4, v2 31-Mar-2021

MUSTANG - CRF 07 Month 6, v2 31-Mar-2021

MUSTANG - CRF 08 Month 8, v2 31-Mar-2021

MUSTANG - CRF 09 Month 10, v2 31-Mar-2021

MUSTANG - CRF 10 Month 12, v2 31-Mar-2021

MUSTANG - CRF 11 Month 14, v2 31-Mar-2021

MUSTANG - CRF 12 Month 16, v2 31-Mar-2021

MUSTANG - CRF 13 Month 18, v2 31-Mar-2021

MUSTANG - CRF 14 Month 20, v2 31-Mar-2021

MUSTANG - CRF 15 Month 22, v2 31-Mar-2021

MUSTANG - CRF 16 Month 24, v2 31-Mar-2021

Privacy Settings